Lexicon Pharmaceuticals recently gained FDA approval for its heart failure and type 2 diabetes drug, Inpefa, and is marketing the drug aggressively. Lexicon's financials show mixed results, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback